Skip to main content
HR 1620 119th Congress House Health Cancer Health care costs and insurance Health care coverage and access Health promotion and preventive care Medicaid Medical tests and diagnostic methods Medicare Poverty and welfare assistance State and local government operations

Finn Sawyer Access to Cancer Testing Act

Introduced: November 10, 2025 Introduced by: Matsui, Doris O. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 26, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 26, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

What's happening now February 26, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Related & companion bills 1
  • S 755 Related bill Finn Sawyer Access to Cancer Testing Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 13
All 13 Democratic 10 Republican 2
D
Pingree, Chellie
Maine · Nov 10, 2025
 D
Tonko, Paul
New York · Nov 7, 2025
 D
Gottheimer, Josh
New Jersey · May 21, 2025
 R
Bacon, Don
Nebraska · Feb 26, 2025
 R
Bilirakis, Gus M.
Florida · Feb 26, 2025
 D
Davis, Donald G.
North Carolina · Feb 26, 2025
 D
Grijalva, Raúl M.
Arizona · Feb 26, 2025
 D
Himes, James A.
Connecticut · Feb 26, 2025
 D
Landsman, Greg
Ohio · Feb 26, 2025
 D
Sewell, Terri A.
Alabama · Feb 26, 2025
 D
Thompson, Mike
California · Feb 26, 2025
 D
Tlaib, Rashida
Michigan · Feb 26, 2025
 D
Wasserman Schultz, Debbie
Florida · Feb 26, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1620: Finn Sawyer Access to Cancer Testing Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1620/
MLA
"H.R. 1620: Finn Sawyer Access to Cancer Testing Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1620/.
Bluebook (legal)
H.R. 1620, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1620/.
Markdown link
[H.R. 1620: Finn Sawyer Access to Cancer Testing Act](https://openamerica.io/bill/119-HR-1620/)
Report a problem